Chronic renal failure in a patient with Sotos syndrome due to autosomal dominant polycystic kidney disease.

Abstract:

:Sotos syndrome is characterised by accelerated growth, acromegalic appearance, mental retardation and social maladjustment. Most cases are sporadic, but familial cases have also been reported. We report a case of Sotos syndrome presenting with chronic renal failure due to autosomal dominant polycystic kidney disease (ADPKD). Ultrasonographic examination of the patient, his father and other family members revealed polycystic kidneys. Renal failure was present only in the Sotos case, who also had considerably larger cysts than other family members. We suggest that the underlying mechanism responsible from the somatic overgrowth in Sotos syndrome may also be linked with the development of larger cysts and earlier onset of renal failure in ADPKD. Although Sotos syndrome has been associated with urological abnormalities, chronic renal failure is very rare. To our knowledge, Sotos syndrome associated with ADPKD has not been reported before.

journal_name

Int J Clin Pract

authors

Cefle K,Yildiz A,Palanduz S,Ozturk S,Ozbey N,Kylyçaslan I,Colakoglu S,Balci C

subject

Has Abstract

pub_date

2002-05-01 00:00:00

pages

316-8

issue

4

eissn

1368-5031

issn

1742-1241

journal_volume

56

pub_type

杂志文章
  • Clinical rationale for rosuvastatin, a potent new HMG-CoA reductase inhibitor.

    abstract::Coronary heart disease (CHD) is the leading cause of death worldwide, and effective treatment of hyperlipidaemia can prevent development of CHD and significantly reduce the risk for cardiovascular events and mortality in this disease. The advent of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors (...

    journal_title:International journal of clinical practice

    pub_type: 杂志文章,评审

    doi:

    authors: Hanefeld M

    更新日期:2001-07-01 00:00:00

  • Efficacy, tolerability and safety of darifenacin, an M(3) selective receptor antagonist: an investigation of warning time in patients with OAB.

    abstract::This double-blind, randomised placebo-controlled, multicentre study evaluated the efficacy, tolerability and safety of 12 weeks' treatment with controlled release darifenacin 15 mg once daily (qd), in 445 patients with overactive bladder (OAB). The primary endpoint was warning time (time from first sensation of urgenc...

    journal_title:International journal of clinical practice

    pub_type: 杂志文章,多中心研究,随机对照试验

    doi:10.1111/j.1368-5031.2005.00770.x

    authors: Zinner N,Susset J,Gittelman M,Arguinzoniz M,Rekeda L,Haab F

    更新日期:2006-01-01 00:00:00

  • Persistence and adherence with mirabegron vs antimuscarinics in overactive bladder: Retrospective analysis of a UK General Practice prescription database.

    abstract:INTRODUCTION AND OBJECTIVES:Persistence with antimuscarinic (AM) drugs prescribed for overactive bladder (OAB) is poor. This study aimed to compare persistence and adherence with the beta-3-adrenoceptor agonist mirabegron (MIR) vs AMs over 12 months. PATIENTS AND METHODS:This retrospective cohort analysis included pat...

    journal_title:International journal of clinical practice

    pub_type: 杂志文章

    doi:10.1111/ijcp.12996

    authors: Wagg AS,Foley S,Peters J,Nazir J,Kool-Houweling L,Scrine L

    更新日期:2017-10-01 00:00:00

  • Impact of Ramadan on demographics and frequencies of disease-related visits in the emergency department.

    abstract::Summary The objective of this study was to determine whether Ramadan is changing frequencies and demographics of visits due to certain diseases. Data obtained from the charts of the adult patients admitted into the emergency department (ED) due to 10 predetermined entities between 2000 and 2004 were analysed. Demograp...

    journal_title:International journal of clinical practice

    pub_type: 杂志文章

    doi:10.1111/j.1742-1241.2005.00460.x

    authors: Topacoglu H,Karcioglu O,Yuruktumen A,Kiran S,Cimrin AH,Ozucelik DN,Sarikaya S,Soysal S,Turpcu U,Bozkurt S

    更新日期:2005-08-01 00:00:00

  • Macroprolactin: what is it and what is its importance?

    abstract::Monomeric prolactin (PRL) of molecular weight 23 kDa constitutes up to 95% of adult serum PRL. Macroprolactin is a large antigen-antibody complex of molecular weight greater than 100 kDa and constitutes less than 1% of circulating PRL. Thus, in most cases, hyperprolactinaemia is usually a result of high levels of mono...

    journal_title:International journal of clinical practice

    pub_type: 杂志文章,评审

    doi:10.1111/j.1368-5031.2006.00732.x

    authors: Sadideen H,Swaminathan R

    更新日期:2006-04-01 00:00:00

  • Headache in essential thrombocythaemia.

    abstract::Headache is frequently reported as one of the neurological manifestations of essential thrombocythaemia (ET) and other myeloproliferative neoplasms. It is associated with considerable morbidity; yet, it is a frequently under-recognised symptom. In patients with ET, headaches may be attributable to the disease, to the ...

    journal_title:International journal of clinical practice

    pub_type: 杂志文章,评审

    doi:10.1111/j.1742-1241.2012.02986.x

    authors: Frewin R,Dowson A

    更新日期:2012-10-01 00:00:00

  • Prevalence of urinary and faecal incontinence and nocturnal enuresis and attitudes to treatment and help-seeking amongst a community-based representative sample of adults in the United Kingdom.

    abstract:AIM:To determine relative prevalence in the same population of urinary incontinence (UI), faecal incontinence (FI) and nocturnal enuresis (NE). To explore attitudes and behaviours relating to help-seeking and beliefs about incontinence prevalence, impact, causes and treatments. DESIGN:Online survey. SUBJECTS:A total ...

    journal_title:International journal of clinical practice

    pub_type: 杂志文章

    doi:10.1111/j.1742-1241.2008.01974.x

    authors: Buckley BS,Lapitan MC

    更新日期:2009-04-01 00:00:00

  • Regression of post-transplant Kaposi's sarcoma using sirolimus.

    abstract::Kaposi's sarcoma (KS) is a recognised complication following kidney transplantation, but the incidence varies according to the geographical area. Although it is a rare tumour, its incidence increases dramatically after solid-organ transplantation. The immunosuppressive medications reactivate human herpes virus 8, whic...

    journal_title:International journal of clinical practice

    pub_type: 杂志文章

    doi:10.1111/j.1742-1241.2006.00815.x

    authors: Kolhe N,Mamode N,Van der Walt J,Pattison J

    更新日期:2006-11-01 00:00:00

  • Autologous transplantation of blood-derived stem/progenitor cells for ischaemic heart disease.

    abstract:AIMS:Early clinical trials suggest that blood-derived stem/progenitor cells (including peripheral blood-derived stem cells and circulating progenitor cells) may have a positive impact on patients with ischaemic heart disease (IHD). The therapeutic effects of these cells remain unclear, considering the inconsistent resu...

    journal_title:International journal of clinical practice

    pub_type: 杂志文章,meta分析,评审

    doi:10.1111/j.1742-1241.2011.02715.x

    authors: Wen Y,Meng L,Ding Y,Ouyang J

    更新日期:2011-08-01 00:00:00

  • The safety and efficacy of formoterol (Oxis) turbuhaler plus budesonide (Pulmicort) turbuhaler in mild to moderate asthma: a comparison with budesonide Turbuhaler alone and current non-corticosteroid therapy in Russia.

    abstract::Current therapy in Russia for long-term management of asthma is mainly non-steroidal. This provided the opportunity to compare the efficacy and safety of formoterol (Oxis) Turbuhaler plus budesonide (Pulmicort) Turbuhaler with budesonide Turbuhaler alone in adults (n=338) with mild to moderate asthma who had little pr...

    journal_title:International journal of clinical practice

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:

    authors: Chuchalin AG,Ovcharenko SI,Goriachkina LA,Sidorenko IV,Tsoi AN,Epoch Study Group.

    更新日期:2002-01-01 00:00:00

  • Five-year experience with tadalafil in the UK: an effective treatment for erectile dysfunction.

    abstract:BACKGROUND:Erectile dysfunction (ED) is a common medical condition. In the UK, approximately 2.3 million men suffer from moderate-to-severe ED, many of whom do not consult a healthcare professional about the problem. Phosphodiesterase-type 5 (PDE5) inhibitors have revolutionised treatment for ED and three such drugs ar...

    journal_title:International journal of clinical practice

    pub_type: 杂志文章,评审

    doi:10.1111/j.1742-1241.2009.02123.x

    authors: Dinsmore W

    更新日期:2009-08-01 00:00:00

  • Development of UK guidance on the management of erectile dysfunction resulting from radical radiotherapy and androgen deprivation therapy for prostate cancer.

    abstract:AIM:To develop a management strategy (rehabilitation programme) for erectile dysfunction (ED) after radiotherapy (RT) or androgen deprivation therapy (ADT) for prostate cancer that is suitable for use in a UK NHS healthcare context. METHODS:PubMed literature searches of ED management in this patient group together wit...

    journal_title:International journal of clinical practice

    pub_type: 杂志文章

    doi:10.1111/ijcp.12512

    authors: White ID,Wilson J,Aslet P,Baxter AB,Birtle A,Challacombe B,Coe J,Grover L,Payne H,Russell S,Sangar V,Van As N,Kirby M

    更新日期:2015-01-01 00:00:00

  • Hyponatraemia in patients with normal pressure hydrocephalus.

    abstract:BACKGROUND:In clinical practice, hyponatraemia was frequently found in patients with hydrocephalus. We conducted this study to determine the prevalence and risk factors for hyponatraemia in patients with normal pressure hydrocephalus (NPH). METHODS:We retrospectively reviewed all patients with NPH who were admitted to...

    journal_title:International journal of clinical practice

    pub_type: 杂志文章

    doi:10.1111/j.1742-1241.2008.01925.x

    authors: Chou CY,Liu JH,Wang SM,Yang YF,Lin HH,Liu YL,Huang CC

    更新日期:2009-03-01 00:00:00

  • Treatment with aliskiren/amlodipine combination in patients with moderate-to-severe hypertension: a randomised, double-blind, active comparator trial.

    abstract:AIMS:To assess the extent of reduction in blood pressure (BP) of aliskiren/amlodipine combination therapy compared with amlodipine monotherapy in moderate-to-severe hypertensive patients. METHODS:This was an 8-week multicentre, randomised, double-blind study. After a 1-to 4-week washout period, eligible patients [mean...

    journal_title:International journal of clinical practice

    pub_type: 杂志文章,多中心研究,随机对照试验

    doi:10.1111/j.1742-1241.2012.02967.x

    authors: Braun-Dullaeus RC,Shustov SB,Alvarez C,Rogelio GG,Zhang J,Hristoskova S,Häring DA

    更新日期:2012-09-01 00:00:00

  • Accelerated atherosclerosis in rheumatoid arthritis and systemic lupus erythematosus.

    abstract::It is important for primary care physicians to recognise rheumatoid arthritis and systemic lupus erythematosus patients as high-risk groups for atherosclerosis, requiring aggressive risk-factor modification. Recent studies suggest that this increased risk is not explained by an excess of traditional risk factors, but ...

    journal_title:International journal of clinical practice

    pub_type: 杂志文章,评审

    doi:10.1111/j.1742-1241.2005.00489.x

    authors: Farzaneh-Far A,Roman MJ

    更新日期:2005-07-01 00:00:00

  • Appropriate choice of proton pump inhibitor therapy in the prevention and management of NSAID-related gastrointestinal damage.

    abstract::Non-steroidal anti-inflammatory drugs (NSAIDs) are associated with gastrointestinal adverse effects, ranging from dyspepsia and peptic ulcer disease to more serious complications such as haemorrhage or perforation. NSAID-induced gastrointestinal toxicity is a significant medical problem worldwide. Misoprostol is effec...

    journal_title:International journal of clinical practice

    pub_type: 杂志文章,评审

    doi:10.1111/j.1368-5031.2005.00660.x

    authors: Singh G,Triadafilopoulos G

    更新日期:2005-10-01 00:00:00

  • Alexia without agraphia: a century later.

    abstract::A case of alexia without agraphia is presented. It is a rare but classic disconnection syndrome, first described by Dejerine in 1892. Recent advances in modern neuroimaging techniques such as FLAIR MRI can now localise in vivo the site of origin of the syndrome, especially when computerised axial tomogram of the brain...

    journal_title:International journal of clinical practice

    pub_type: 杂志文章

    doi:

    authors: Imtiaz KE,Nirodi G,Khaleeli AA

    更新日期:2001-04-01 00:00:00

  • The prevalence of gout in an urban area of Izmir, Turkey: a population-based epidemiological study.

    abstract:OBJECTIVES:This study aimed to determine the prevalence of gout in a general Turkish population, according to the American College of Rheumatology (Wallace) criteria proposed for gout classification. METHODS:This study was conducted in two districts of Izmir Province in Turkey, and involved 2835 subjects of ≥ 20 years...

    journal_title:International journal of clinical practice

    pub_type: 杂志文章

    doi:10.1111/ijcp.12377

    authors: Birlik M,Gurler O,Akar S,Sari I,Onen F,Akkoc N

    更新日期:2014-06-01 00:00:00

  • Comparison of the efficacy of silodosin and a terpene combination in the medical expulsive therapy of distal ureteral stones.

    abstract:OBJECTIVE:We aimed to compare the efficacy of silodosin and a terpene combination in the treatment of distal ureteral stones. METHODOLOGY:The data of the patients admitted to the urology policlinic with renal colic, diagnosed with distal ureteral stones, and followed up with medical expulsive therapy between December ...

    journal_title:International journal of clinical practice

    pub_type: 杂志文章

    doi:10.1111/ijcp.13866

    authors: Sahin MO,Sen V,Ongun S,Irer B,Yildiz G

    更新日期:2020-11-24 00:00:00

  • Therapeutic comparison of a new budesonide/formoterol pMDI with budesonide pMDI and budesonide/formoterol DPI in asthma.

    abstract:BACKGROUND:Budesonide/formoterol is an effective treatment for both asthma and chronic obstructive pulmonary disease. This study compared the efficacy and safety of a novel hydrofluoroalkane (HFA) pressurised metered-dose inhaler (pMDI) formulation of budesonide/formoterol with that of budesonide pMDI and budesonide/fo...

    journal_title:International journal of clinical practice

    pub_type: 杂志文章,多中心研究,随机对照试验

    doi:10.1111/j.1742-1241.2007.01574.x

    authors: Morice AH,Peterson S,Beckman O,Osmanliev D

    更新日期:2007-11-01 00:00:00

  • Clinimetrics: the science of clinical measurements.

    abstract::'Clinimetrics' is the term introduced by Alvan R. Feinstein in the early 1980s to indicate a domain concerned with indexes, rating scales and other expressions that are used to describe or measure symptoms, physical signs and other clinical phenomena. Clinimetrics has a set of rules that govern the structure of indexe...

    journal_title:International journal of clinical practice

    pub_type: 杂志文章,评审

    doi:10.1111/j.1742-1241.2011.02825.x

    authors: Fava GA,Tomba E,Sonino N

    更新日期:2012-01-01 00:00:00

  • Spontaneous remission of large granular lymphocytic leukaemia.

    abstract::The phenomenon of spontaneous remission is one of the less well known aspects of the leukaemias. Spontaneous remission has been reported in both acute and chronic leukaemia. The mechanism is unclear but may involve immune modulation related to an intercurrent infection or transfusion of blood products. We present a ra...

    journal_title:International journal of clinical practice

    pub_type: 杂志文章

    doi:

    authors: Sosin MD,Handa SI

    更新日期:2003-07-01 00:00:00

  • Restless hand symptoms in carpal tunnel syndrome.

    abstract::Carpal tunnel syndrome (CTS) is a nerve entrapment disorder, involving the median nerve when it passes the carpal tunnel at the wrist. Using a case-control methodology, 312 electrophysiologically confirmed CTS patients with mean age of 51.3+/-9.4 (27-74) years (81.7% women) and 100 controls with mean age of 50.4+/-9.2...

    journal_title:International journal of clinical practice

    pub_type: 杂志文章

    doi:10.1111/j.1742-1241.2004.00113.x

    authors: Tan EK,Koh KK,Arulanandam S,Lo YL

    更新日期:2004-11-01 00:00:00

  • Helicobacter pylori eradication--comparison of three drug regimens and symptomatic assessment in duodenitis and antral gastritis.

    abstract::Helicobacter pylori (Hp) eradication in peptic ulcer disease is associated with a greatly reduced recurrence rate. The optimal drug regimen for HP eradication remains uncertain. It is also unclear if eradication of Hp in duodenitis and antral gastritis improves symptoms. The aims of this study were to compare the effi...

    journal_title:International journal of clinical practice

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:

    authors: Tan WC,Hogan J,Purkayastha SK,Lombard M,Krasner N

    更新日期:1997-06-01 00:00:00

  • The impact of age on 6-month survival in patients with cardiovascular risk factors undergoing elective non-cardiac surgery.

    abstract::An increasing number of patients aged>or=70 years are presenting for elective non-cardiac surgery. We undertook this study to: (i) compare the nature and distribution of cardiovascular disease (CVD) risk factors in an at risk population of patients aged>or=70 years undergoing elective surgery compared with a younger a...

    journal_title:International journal of clinical practice

    pub_type: 杂志文章

    doi:10.1111/j.1742-1241.2007.01304.x

    authors: Naughton C,Feneck RO

    更新日期:2007-05-01 00:00:00

  • Impact of cerebrovascular pathology on behavioural and neuropsychiatric symptoms in patients with Alzheimer's dementia: findings from a retrospective, naturalistic study.

    abstract:AIM:Cerebrovascular disease (CVD) has been associated with depression and a host of neuropsychiatric conditions including dementia. This study assessed the relationship between cerebrovascular findings reported on MRI brain scans and neuropsychiatric symptoms (NPS) and behavioural problems in patients with Alzheimer's ...

    journal_title:International journal of clinical practice

    pub_type: 杂志文章

    doi:10.1111/j.1742-1241.2009.02079.x

    authors: Klugman A,Marshall J,Tabet N

    更新日期:2009-07-01 00:00:00

  • Asenapine for schizophrenia and bipolar disorder: a review of the efficacy and safety profile for this newly approved sublingually absorbed second-generation antipsychotic.

    abstract:OBJECTIVE:To describe the efficacy and safety of asenapine for the treatment of schizophrenia and bipolar disorder. DATA SOURCES:The pivotal registration trials were accessed by querying http://www.pubmed.gov, http://www.fda.gov and http://www.clinicaltrials.govfor the search terms 'asenapine' or 'ORG 5222'. STUDY SE...

    journal_title:International journal of clinical practice

    pub_type: 杂志文章,meta分析,评审

    doi:10.1111/j.1742-1241.2009.02228.x

    authors: Citrome L

    更新日期:2009-12-01 00:00:00

  • Effects of exenatide twice daily, exenatide once weekly or insulin in patients with type 2 diabetes and baseline HbA1c ≥10.0%: Two pooled analyses including 20 randomised controlled trials.

    abstract:AIMS:Patients with advanced type 2 diabetes (T2D) and high glycated haemoglobin (HbA1c) values can be difficult to treat because of their severe metabolic disease. This pooled analysis examined the treatment effects of exenatide twice daily (BID), exenatide once weekly (QW) and insulin in patients with high baseline Hb...

    journal_title:International journal of clinical practice

    pub_type: 杂志文章,meta分析,评审

    doi:10.1111/ijcp.13029

    authors: Busch RS,Ruggles J,Han J,Hardy E

    更新日期:2017-12-01 00:00:00

  • Targets and tactics: the relative importance of HbA, fasting and postprandial plasma glucose levels to glycaemic control in type 2 diabetes.

    abstract:BACKGROUND:The incidence of type 2 diabetes is reaching pandemic proportions, impacting patients and healthcare systems across the globe. Evidence suggests that a majority of patients are not achieving recommended blood glucose targets resulting in an increased risk of micro- and macro-vascular complications. AIM:To r...

    journal_title:International journal of clinical practice

    pub_type: 杂志文章,评审

    doi:10.1111/j.1742-1241.2008.01941.x

    authors: Woo V,Shestakova MV,Ørskov C,Ceriello A

    更新日期:2008-12-01 00:00:00

  • Denosumab: mechanism of action and clinical outcomes.

    abstract:AIMS:To describe the mechanisms of action of denosumab, a novel antiresorptive agent, contrasting it with other antiresorptive and anabolic osteoporosis treatments. METHODS:Published papers related to the mechanism of action of approved osteoporosis treatments were sought through MEDLINE searches. FINDINGS:Osteoporot...

    journal_title:International journal of clinical practice

    pub_type: 杂志文章,评审

    doi:10.1111/ijcp.12022

    authors: Hanley DA,Adachi JD,Bell A,Brown V

    更新日期:2012-12-01 00:00:00